3100 SW 62nd Ave, Miami, FL, 33155 · (305) 666-6511
Beds
278
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$927.4M
FY 2025
Net income
$111.1M
Patient care margin 3.6%
Discharges
10,302
Occupancy 57.5%
Clinicians
9
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $927.4M | $893.9M | 3.6% | $111.1M | 10,302 | - | 0.3% | 7.3% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | - | - | - | $1,219.56 |
| APC 5372 Level 2 Urology and Related Services | - | - | - | $502.15 |
| APC 5373 Level 3 Urology and Related Services |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $959.8M | $884.8M | 7.8% | $120.7M | 10,695 | $8.5M | 0.0% | 9.9% |
| 2023 | - | $822.2M | - | -$822.2M | 10,486 | $7.1M | 0.1% | 9.6% |
| 2022 | $769.3M | $726.9M | 5.5% | -$4.3M | 10,029 | $5.6M | 0.1% | 10.2% |
| 2021 | $714.9M | $641.6M | 10.3% | $76.2M | 9,509 | - | 0.1% | 6.9% |
| 2020 | $490.7M | $635.9M | -29.6% | $12.6M | 8,170 | - | 0.4% | 11.2% |
| - |
| - |
| - |
| $1,516.28 |
| APC 5374 Level 4 Urology and Related Services | - | - | - | $2,629.24 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. RARE | 10 | $264K |
| Ucb Sa UCB.BR | 4 | $134K |
| Merit Medical Systems Inc MMSI | 15 | $70K |
| Hoffmann-La Roche Limited ROG.SW | 23 | $64K |
| BioMarin Pharmaceutical Inc. BMRN | 4 | $46K |
| H. Lundbeck A S HLUN-A.CO | 6 | $43K |
| Pfizer Inc. PFE | 7 | $28K |
| Eli Lilly and Company LLY | 1 | $25K |
| ModernaTX, Inc. MRNA | 1 | $24K |
| Day One Biopharmaceuticals DAWN | 1 | $23K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Nicklaus Children's Hospital is a nonprofit children's hospital in Miami, FL with 278 beds, part of Nicklaus Childrens Health System.
Nicklaus Children's Hospital in Miami, FL has 278 beds (fiscal year 2025 cost report); 474 beds are certified for Medicare. It discharged 10,302 inpatients that year, with 57.5% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Nicklaus Children's Hospital reported net patient revenue of $927.4M and operating expenses of $893.9M, a margin on patient care of 3.6%. After other income and expenses its net income was $111.1M (10.7% of revenue), so it made a profit that year.
Nicklaus Children's Hospital is part of Nicklaus Childrens Health System, a health system with 1 hospitals based in Miami, FL. It is a nonprofit hospital.
Nicklaus Children's Hospital has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, Nicklaus Children's Hospital provides emergency services.
9 Medicare clinicians list Nicklaus Children's Hospital as a hospital they work at, most often in Cardiovascular Disease (Cardiology), Pediatric Medicine, General Surgery.
In 2025, companies reported $935K in payments to Nicklaus Children's Hospital as a teaching hospital ($53K general and $882K for research) from 35 companies.